These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16003242)

  • 1. Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetes patients.
    van Kampen CA; van de Linde P; Duinkerken G; van Schip JJ; Roelen DL; Keymeulen B; Pipeleers DG; Claas FH; Roep BO
    Transplantation; 2005 Jul; 80(1):118-26. PubMed ID: 16003242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation.
    Roelen DL; Huurman VA; Hilbrands R; Gillard P; Duinkerken G; van der Meer-Prins PW; Versteeg-van der Voort Maarschalk MF; Mathieu C; Keymeulen B; Pipeleers DG; Roep BO; Claas FH
    Clin Exp Immunol; 2009 Apr; 156(1):141-8. PubMed ID: 19161445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients.
    Roep BO; Stobbe I; Duinkerken G; van Rood JJ; Lernmark A; Keymeulen B; Pipeleers D; Claas FH; de Vries RR
    Diabetes; 1999 Mar; 48(3):484-90. PubMed ID: 10078547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.
    Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH
    Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization to HLA antigens in islet recipients with failing transplants.
    Olack BJ; Swanson CJ; Flavin KS; Phelan D; Brennan DC; White NH; Lacy PE; Scharp DW; Poindexter N; Mohanakumar T
    Transplant Proc; 1997 Jun; 29(4):2268-9. PubMed ID: 9193621
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictive factors of allosensitization after immunosuppressant withdrawal in recipients of long-term cultured islet cell grafts.
    Hilbrands R; Gillard P; Van der Torren CR; Ling Z; Verheyden S; Jacobs-Tulleneers-Thevissen D; Roep BO; Claas FH; Demanet C; Gorus FK; Pipeleers D; Keymeulen B
    Transplantation; 2013 Jul; 96(2):162-9. PubMed ID: 23857001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
    Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
    Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft.
    Keymeulen B; Ling Z; Gorus FK; Delvaux G; Bouwens L; Grupping A; Hendrieckx C; Pipeleers-Marichal M; Van Schravendijk C; Salmela K; Pipeleers DG
    Diabetologia; 1998 Apr; 41(4):452-9. PubMed ID: 9562350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients.
    Hilbrands R; Huurman VA; Gillard P; Velthuis JH; De Waele M; Mathieu C; Kaufman L; Pipeleers-Marichal M; Ling Z; Movahedi B; Jacobs-Tulleneers-Thevissen D; Monbaliu D; Ysebaert D; Gorus FK; Roep BO; Pipeleers DG; Keymeulen B
    Diabetes; 2009 Oct; 58(10):2267-76. PubMed ID: 19602536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Donor Origin and Condition of Transplanted Islets In Situ in the Liver of a Type 1 Diabetic Recipient.
    van der Torren CR; Suwandi JS; Lee D; Van't Wout ET; Duinkerken G; Swings G; Mulder A; Claas FH; Ling Z; Gillard P; Keymeulen B; In't Veld P; Roep BO
    Cell Transplant; 2017 Jan; 26(1):1-9. PubMed ID: 27729094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts.
    Jaeger C; Brendel MD; Hering BJ; Eckhard M; Bretzel RG
    Diabetes; 1997 Nov; 46(11):1907-10. PubMed ID: 9356046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fresh human islet transplantation to replace pancreatic endocrine function in type 1 diabetic patients. Report of six cases.
    Socci C; Falqui L; Davalli AM; Ricordi C; Braghi S; Bertuzzi F; Maffi P; Secchi A; Gavazzi F; Freschi M
    Acta Diabetol; 1991; 28(2):151-7. PubMed ID: 1777651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses against islet allografts during tapering of immunosuppression--a pilot study in 5 subjects.
    Huurman VA; van der Torren CR; Gillard P; Hilbrands R; van der Meer-Prins EP; Duinkerken G; Gorus FK; Claas FH; Keymeulen B; Roelen DL; Pipeleers DG; Roep BO
    Clin Exp Immunol; 2012 Aug; 169(2):190-8. PubMed ID: 22774994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
    Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA
    Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of cytomegalovirus infections after immunosuppression induction in clinical islet transplantation and impact on graft function.
    Eckhard M; Martin I; Eich T; Weimer R; Zinn S; Bretzel RG; Brendel MD
    Transplant Proc; 2002 Aug; 34(5):1922-4. PubMed ID: 12176630
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
    Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
    Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation.
    Campbell PM; Salam A; Ryan EA; Senior P; Paty BW; Bigam D; McCready T; Halpin A; Imes S; Al Saif F; Lakey JR; Shapiro AM
    Am J Transplant; 2007 May; 7(5):1242-8. PubMed ID: 17456201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring human islet allografts using a forearm biopsy site.
    Stegall MD
    Ann Transplant; 1997; 2(3):8-11. PubMed ID: 9869858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients.
    Scharp DW; Lacy PE; Santiago JV; McCullough CS; Weide LG; Boyle PJ; Falqui L; Marchetti P; Ricordi C; Gingerich RL
    Transplantation; 1991 Jan; 51(1):76-85. PubMed ID: 1987709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.
    Lakey JR; Singh B; Warnock GL; Rajotte RV
    Transplantation; 1994 Apr; 57(8):1213-7. PubMed ID: 8178349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.